In vitro growth inhibition by indomethacin on human oral squamous cell carcinoma lines synergistically suppressed by all-trans retinoic acid correlating to apoptosis

Chinese Medical Journal (Taipei)

Volumn 65, Issue 12, 2003, Pages 600-607

  Yang, Cheng Chieh ^a   Tu, Shi Fen ^a   Wu, Cheng Hsien ^a   Chang, Richard Che Shoa ^a   Kao, Shou Yen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Growth inhibition; Human oral cancer; Indomethacin; Retinoic acid

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; INDOMETACIN; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CLONE; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUTH CARCINOMA; NICK END LABELING; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DRUG SYNERGISM; HUMANS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; MOUTH NEOPLASMS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037413199     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Frank GO. Arachidonic acid metabolism: a primer for head and neck surgeons. Head Neck 1998;20:334-49.
2. Jaffe BM, Santoro MG. Prostaglandins and cancer. In: Ramwell PW, ed. The Prostaglandins. New York: Plenum, 1997.
3. Peter A. Prostaglandins and cancer. Nature 1982;295:188-9.
4. Reuven R, George RM. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins 1996;51:1-17.
5. Kenneth AS, Carl HS, Robert R, Jaya R, Frank DA, Seia C, et al. Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs. Am J Otolarygol 1997;18:1-8.
6. Frank GO, Steven KJ, George LA. Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition. Larygoscope 1996;106:129-34.
7. Kotha S, David Z, Babette BW, Andrew JD. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 1997;216:201-10.
8. Makoto MT. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Nat Cancer Inst 1998;90:1529-36.
9. Makoto MT. Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Nat Cancer Inst 1998;90:1609-20.
10. 3. Leukemia 1994;8:595-604.
11. Franklin CD, Craig GT. The effect of indomethacin on tumor regression in DMBA-induced epithelial neoplasia of hamster cheek pouch mucosa. Oral Surg Oral Med Oral Path 1987;63:335-9.
12. Yang CC, Tu SF, Chang CSR, Kao SY. In vitro cellular response of retinoic acid treated human oral cancer cell lines. Chin Med J (Taipei) 2001;64:357-63.
13. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-5.
14. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Beyers RM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990;323:825-7.
15. Rheinwald JG, Beckett MA. Tumorigenic Keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41:1657-63.
16. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, ZurHausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
17. Rheinwald JG, Beckett MA. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 1980;22:629-32.
18. Daniel YKW, Kuo WC, Chien FC, Richard CSC. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas - OC1 and OC2. J Oral Maxillofac Surg 1990;48:385-90.
19. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996;52:237-45.
20. Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cell: effects on cell cycle and apoptosis. Exp Cell Res 1996;222:179-88.
21. Zhu GH, Wong BCY, Eggo MC, Ching CK, Yuen ST, Chan YET, et al. Non-steroid anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Bri J Cancer 1999;79:393-400.
22. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994;54:3391-5.
23. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E, Prendergast GC. C-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanism. Oncogene 1995;11:2411-8.
24. Kelloff GJ, Fay JR, Steele VE, Lubet RA, Boone CW, Crowell JA, et al. Epidemal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Boimarkers & Prev 1996;5657-66.
25. Hamasaki Y, Kitzler J, Hardman R, Nettesheim P, Eling TE. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophy 1993;304:226-34.
26. Eling TW, Thompson DC, Foureman GL, Curtis JF, Hughes MF. Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol 1990;30:1-45.
27. Xie W, Herschman HR. v-src induces prosthaglandin synthase 2 gene expression by activation of c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 1995;270:27622-8.
28. Schule R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Aca Sci USA 1991;88:6092-6.
29. Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, et al. Retinoic acid receptors and retinoid X receptor-α downregulate the transforming growth factor-B1 promoter by antagonizing AP-1 activity. Mol Endocrinol 1993;7:1347-56.
30. Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, et al. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res 1997;57:2890-5.